Condition (MeSH)
Conjunctivitis, Viral
ClinicalTrials.gov lists 14 trials for Conjunctivitis, Viral or a narrower condition beneath it. NicOx has the most among industry and government lead sponsors, with 5.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
14 of the 14 trials are tagged with Conjunctivitis, Viral itself; the rest are tagged with a narrower condition beneath it.
When did Conjunctivitis, Viral trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2018 | 1 |
| 2015 | 1 |
| 2014 | 3 |
| 2013 | 2 |
| 2012 | 1 |
| 2011 | 1 |
| 2009 | 2 |
| 2004 | 2 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 14 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Conjunctivitis, Viral trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 4 |
| Observational | 6 |
How many Conjunctivitis, Viral trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 13 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Conjunctivitis, Viral trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| NicOx | 5 |
| Rapid Pathogen Screening | 2 |
| Adenovir Pharma AB | 1 |
Which drugs are being tested for Conjunctivitis, Viral? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Ganciclovir | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Preservative free artificial tear | 1 |
| dexamethasone 0.1%/povidone-iodine 0.4% | 1 |
| Artificial Tear | 1 |
| Ketorolac trometamol 0.45% with carboxymethylcellulose | 1 |
| 0.01% hypochlorous acid | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
How do Conjunctivitis, Viral trials deliver against plan? (1)
Shown in this order: one row, this condition's own record. Enrollment hit target: the share of trials mapped to this condition whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 0 of 2 hit target (n=2); 12 of 14 trials not graded | 1 of 2 on time (n=2); 12 of 14 trials not graded |
Delivery grades from ClinicalTrials.gov / AACT (CTTI) planned-vs-actual history, public domain.
Which publications cover Conjunctivitis, Viral? (17)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study. | Cornea | 2021 | Yes |
| Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study. | Optometry and vision science : official publication of the American Academy of Optometry | 2021 | Yes |
| Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. | The British journal of ophthalmology | 2020 | Yes |
| Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. | Acta ophthalmologica | 2020 | Yes |
| Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. | JAMA ophthalmology | 2013 | Yes |
Showing 5 of 17 publications.
Not on this page
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.